PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II, widely researched for its central nervous system-mediated effects. Preclinical and in-vitro studies focus on its activation of MC3R/MC4R pathways, modulation of dopaminergic signaling, and investigation of sexual motivation, arousal responses, and appetite regulation in animal models.
• Purity: ≥99% (HPLC verified)
• Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
• CAS No.: 189691-06-3
• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
• Molecular Weight: 1025.2 g/mol
• Form: Lyophilized powder
• Solubility: Reconstitute with bacteriostatic water or sterile saline • Storage: Freeze-dried at -20°C; reconstituted at 2–8°C for up to 30 days • Includes: Third-party Certificate of Analysis (COA) with every order
Disclaimer: This product is sold strictly for laboratory and in-vitro research purposes only. It is not intended for human or animal consumption, medical, diagnostic, therapeutic, or veterinary use. Not evaluated by Health Canada or the FDA. The purchaser is solely responsible for ensuring compliance with all applicable laws and regulations in Quebec, Canada.
